FDA Says Inspection Revealed Cue Health Is Not Complying With Some Conditions Of Authorization In Letters Of Authorization For EUA200248 & EUA210180
Portfolio Pulse from Benzinga Newsdesk
The FDA has found that Cue Health is not adhering to certain conditions of authorization specified in the Letters of Authorization for EUA200248 & EUA210180, according to Reuters.
May 13, 2024 | 4:40 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cue Health's non-compliance with FDA authorization conditions could lead to regulatory actions, impacting investor confidence and potentially the company's stock price.
The FDA's findings of non-compliance for Cue Health directly impact the company's operational integrity and could lead to regulatory actions such as fines, or a mandate to meet compliance standards, which may incur additional costs. This situation can affect investor confidence, leading to a negative short-term impact on HLTH's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90